What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
- 30 June 2003
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 145 (6) , 971-978
- https://doi.org/10.1016/s0002-8703(03)00104-2
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimenJournal of the American College of Cardiology, 2001
- Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac EventsCirculation, 2001
- Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirinThe American Journal of Cardiology, 1999
- Coronary-Artery Stents — Gauging, Gorging, and GougingNew England Journal of Medicine, 1998
- The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non–Q-wave myocardial infarctionsJournal of the American College of Cardiology, 1998
- Subacute stent thrombosis: Evolving issues and current conceptsJournal of the American College of Cardiology, 1996
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994
- A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery DiseaseNew England Journal of Medicine, 1994
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.Circulation, 1987